Clinical Trial Update: Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating insulin efficacy and safety in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED